February 15, 2018
Otsuka Holdings President Tatsuo Higuchi Otsuka Holdings saw its pharmaceutical segment sales tick up nearly 3% in 2017 as sliding sales of its flagship antipsychotic Abilify (aripiprazole) following its patent expirations were covered by newer global products. “Our sales have...read more